The REMAP-CAP Investigators. Interleukin-6 receptor antagonists in critically ill patients with Covid-19. N Engl J Med. DOI: 10.1056/NEJMoa2100433.
Salama C, Han J, Yau L et al (2020) Tocilizumab in patients hospitalized with Covid-19 pneumonia. N Engl J Med. https://doi.org/10.1056/NEJMoa2030340
Ontario COVID-19 Drugs and Biologics Clinical Practice Guidelines Working Group Therapeutic Management of Adult Patients with COVID-19. Accessed online August 30, 2021 from: https://covid19-sciencetable.ca/wp-content/uploads/2021/08/CPGSummary_final.pdf
RECOVERY Collaborative Group. Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): preliminary results of a randomised, controlled, open-label, platform trial. Preprint from Feb 11, 2021. DOI: https://doi.org/10.1101/2021.02.11.21249258